RecruitingNCT04265040
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Studying AA amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Heidelberg
- Enrollment
- 2040 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2020 – 2027
Study locations (1)
- University Hospital Heidelberg - Clinic of Cardiology, Angiology and Pneumology, Heidelberg, Baden-Wurttemberg, Germany
Collaborators
University Medicine Greifswald · Charite University, Berlin, Germany · German Heart Center · University of Mannheim · University Hospital Schleswig-Holstein · Medical University of Hannover · Goethe University · Universitätsklinikum Hamburg-Eppendorf · University Medical Center Mainz · University Medical Center Goettingen · Deutsches Herzzentrum Muenchen · Technical University of Munich · University Hospital Munich · Kerckhoff Klinik
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04265040 on ClinicalTrials.govOther trials for AA amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06974877Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT06354322Unclassified GENotypes of Autoinflammatory Diseases and AA AmyloidosisAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGNANCT03584022Clinical Trial to Assess the Safety of a Novel Scaffold BiomaterialMayo Clinic